In our bulk RNA-seq data, we find only modest ELTD1 expression in patient-derived GBM cells; however, we have included it in this review due to extensive available literature implicating the receptor in GBM biology and associated angiogenesis (Figure 1A). This evidence concerns the gene ADGRL4 and glioblastoma.